Invention Grant
- Patent Title: Use of iron for treating attention deficit hyperactivity disorder in children
-
Application No.: US10559293Application Date: 2004-06-01
-
Publication No.: US10532100B2Publication Date: 2020-01-14
- Inventor: Eric Konofal
- Applicant: Eric Konofal
- Applicant Address: CH Stans
- Assignee: NLS PHARMA AG
- Current Assignee: NLS PHARMA AG
- Current Assignee Address: CH Stans
- Agency: Norton Rose Fulbright US LLP
- Priority: FR0306581 20030530
- International Application: PCT/FR2004/001351 WO 20040601
- International Announcement: WO2004/105744 WO 20041209
- Main IPC: A61K45/06
- IPC: A61K45/06

Abstract:
The invention relates to the use of iron for preparing a medicament for the preventive and/or curative treatment of attention deficit hyperactivity disorder (ADHD) or at least one of the symptoms thereof, for a patient requiring such treatment.
Public/Granted literature
- US20060147552A1 Use of iron for treating attention deficit hyperactivity disorder in children Public/Granted day:2006-07-06
Information query